These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 34268440)

  • 1. Platelet lysate for COVID-19 pneumonia-a newer adjunctive therapeutic avenue.
    Jeyaraman M; Muthu S; Khanna M; Jain R; Anudeep TC; Muthukanagaraj P; Siddesh SE; Gulati A; Satish AS; Jeyaraman N; Khanna V
    Stem Cell Investig; 2021; 8():11. PubMed ID: 34268440
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Umbilical Cord-derived Mesenchymal Stem Cells for COVID-19 Patients with Acute Respiratory Distress Syndrome (ARDS).
    Lanzoni G; Linetsky E; Correa D; Alvarez RA; Marttos A; Hirani K; Cayetano SM; Castro JG; Paidas MJ; Efantis Potter J; Xu X; Glassberg M; Tan J; Patel AN; Goldstein B; Kenyon NS; Baidal D; Alejandro R; Vianna R; Ruiz P; Caplan AI; Ricordi C
    CellR4 Repair Replace Regen Reprogram; 2020; 8():. PubMed ID: 34164564
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Platelet Lysate Nebulization Protocol for the Treatment of COVID-19 and Its Sequels: Proof of Concept and Scientific Rationale.
    Beitia M; Delgado D; Sánchez P; Vallejo de la Cueva A; Cugat JR; Sánchez M
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33673372
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Δ9-Tetrahydrocannabinol Prevents Mortality from Acute Respiratory Distress Syndrome through the Induction of Apoptosis in Immune Cells, Leading to Cytokine Storm Suppression.
    Mohammed A; F K Alghetaa H; Miranda K; Wilson K; P Singh N; Cai G; Putluri N; Nagarkatti P; Nagarkatti M
    Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32872332
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cellular Therapy: Shafts of Light Emerging for COVID-19.
    Jeyaraman M; Ranjan R; Kumar R; Arora A; Chaudhary D; Ajay SS; Jain R
    Stem Cell Investig; 2020; 7():11. PubMed ID: 32695804
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Possible mechanisms responsible for acute coronary events in COVID-19.
    Sheth AR; Grewal US; Patel HP; Thakkar S; Garikipati S; Gaddam J; Bawa D
    Med Hypotheses; 2020 Oct; 143():110125. PubMed ID: 32763657
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nutraceutical Targeting of Inflammation-Modulating microRNAs in Severe Forms of COVID-19: A Novel Approach to Prevent the Cytokine Storm.
    Desjarlais M; Wirth M; Lahaie I; Ruknudin P; Hardy P; Rivard A; Chemtob S
    Front Pharmacol; 2020; 11():602999. PubMed ID: 33362557
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypothesis for the management and treatment of the COVID-19-induced acute respiratory distress syndrome and lung injury using mesenchymal stem cell-derived exosomes.
    Taghavi-Farahabadi M; Mahmoudi M; Soudi S; Hashemi SM
    Med Hypotheses; 2020 Nov; 144():109865. PubMed ID: 32562911
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunothrombotic Dysregulation in COVID-19 Pneumonia Is Associated With Respiratory Failure and Coagulopathy.
    Nicolai L; Leunig A; Brambs S; Kaiser R; Weinberger T; Weigand M; Muenchhoff M; Hellmuth JC; Ledderose S; Schulz H; Scherer C; Rudelius M; Zoller M; Höchter D; Keppler O; Teupser D; Zwißler B; von Bergwelt-Baildon M; Kääb S; Massberg S; Pekayvaz K; Stark K
    Circulation; 2020 Sep; 142(12):1176-1189. PubMed ID: 32755393
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Specific cytokines in the inflammatory cytokine storm of patients with COVID-19-associated acute respiratory distress syndrome and extrapulmonary multiple-organ dysfunction.
    Wang J; Yang X; Li Y; Huang JA; Jiang J; Su N
    Virol J; 2021 Jun; 18(1):117. PubMed ID: 34088317
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mesenchymal stem cells as living anti-inflammatory therapy for COVID-19 related acute respiratory distress syndrome.
    Lin F; Ichim TE; Pingle S; Jones LD; Kesari S; Ashili S
    World J Stem Cells; 2020 Oct; 12(10):1067-1079. PubMed ID: 33178392
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Unraveled roles of hyaluronan in severe COVID-19.
    Ontong P; Prachayasittikul V
    EXCLI J; 2021; 20():117-125. PubMed ID: 33564281
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tocilizumab in SARS-CoV-2 Patients with the Syndrome of Cytokine Storm: A Narrative Review.
    Kulanthaivel S; Kaliberdenko VB; Balasundaram K; Shterenshis MV; Scarpellini E; Abenavoli L
    Rev Recent Clin Trials; 2021; 16(2):138-145. PubMed ID: 32940187
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mast cells activated by SARS-CoV-2 release histamine which increases IL-1 levels causing cytokine storm and inflammatory reaction in COVID-19.
    Conti P; Caraffa A; Tetè G; Gallenga CE; Ross R; Kritas SK; Frydas I; Younes A; Di Emidio P; Ronconi G
    J Biol Regul Homeost Agents; 2020 Sep-Oct,; 34(5):1629-1632. PubMed ID: 32945158
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current status of mesenchymal stem cell therapy for immune/inflammatory lung disorders: Gleaning insights for possible use in COVID-19.
    Yen BL; Yen ML; Wang LT; Liu KJ; Sytwu HK
    Stem Cells Transl Med; 2020 Oct; 9(10):1163-1173. PubMed ID: 32526079
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A prospective, randomized, controlled study assessing vagus nerve stimulation using the gammaCore®-Sapphire device for patients with moderate to severe CoViD-19 Respiratory Symptoms (SAVIOR): A structured summary of a study protocol for a randomised controlled trial".
    Tornero C; Vallejo R; Cedeño D; Orduña J; Pastor E; Belaouchi M; Escamilla B; Laredo M; Del Mar Garzando M
    Trials; 2020 Jun; 21(1):576. PubMed ID: 32586395
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Placenta-derived mesenchymal stem cells (P-MSCs) for COVID-19 pneumonia-a regenerative dogma.
    Siddesh SE; Gowda DM; Jain R; Gulati A; Patil GS; Anudeep TC; Jeyaraman N; Muthu S; Jeyaraman M
    Stem Cell Investig; 2021; 8():3. PubMed ID: 33688491
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic potential of mesenchymal stem cells and their exosomes in severe novel coronavirus disease 2019 (COVID-19) cases.
    Tsuchiya A; Takeuchi S; Iwasawa T; Kumagai M; Sato T; Motegi S; Ishii Y; Koseki Y; Tomiyoshi K; Natsui K; Takeda N; Yoshida Y; Yamazaki F; Kojima Y; Watanabe Y; Kimura N; Tominaga K; Kamimura H; Takamura M; Terai S
    Inflamm Regen; 2020; 40():14. PubMed ID: 32582401
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognosis of COVID-19: Red Cell Distribution Width, Platelet Distribution Width, and C-Reactive Protein.
    Bommenahalli Gowda S; Gosavi S; Ananda Rao A; Shastry S; Raj SC; Menon S; Suresh A; Sharma A
    Cureus; 2021 Feb; 13(2):e13078. PubMed ID: 33680618
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transplantation of Mesenchymal Stem Cells: A Potential Adjuvant Therapy for COVID-19.
    Zhu Y; Geng S; Li Q; Jiang H
    Front Bioeng Biotechnol; 2020; 8():557652. PubMed ID: 33224928
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.